rs11977670: Understanding Your Genetic Predisposition to ILC
The genetic variant rs11977670 is a single nucleotide polymorphism located in an intergenic region on chromosome 7. Research has identified this variant as a specific genetic predisposition factor associated with an increased risk of developing invasive lobular breast cancer.
What each genotype means
Baseline lobular cancer risk
This genotype represents the common baseline state for this genetic location. Research indicates that individuals with this genotype do not carry the specific genetic association linked to an increased risk of invasive lobular breast cancer. Please note that this does not eliminate your overall risk for breast cancer, and you should continue to follow standard screening guidelines recommended by your healthcare provider.
This is the most common genotype observed in populations of European ancestry.
Slightly increased lobular risk
This genotype is associated with a statistically significant, modest increase in the risk of developing invasive lobular breast cancer. The association is specific to lobular subtypes and shows little to no correlation with other common breast cancer types. You should discuss your family history and appropriate breast cancer screening strategies with your physician.
This genotype is found in a significant portion of the population, with frequencies varying by ancestry.
Elevated lobular cancer risk
Carrying two copies of this allele is associated with a higher statistical predisposition to invasive lobular breast cancer compared to those without the variant. While this finding is significant in research studies, it is only one of many factors that contribute to cancer risk. It is important to maintain regular clinical check-ups and discuss personalized screening options with your healthcare provider.
This genotype is less common than the G/G or G/A genotypes in most studied populations.
What is rs11977670?
The variant rs11977670 is a single nucleotide polymorphism (SNP) located at the 7q34 locus on chromosome 7. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is classified as intergenic, meaning it resides in the DNA sequence between genes rather than within a gene that codes for a protein. Because it is located in a non-coding region, it does not directly alter the structure of a protein. Instead, researchers investigate such variants to determine if they influence the regulation of nearby genes or serve as markers for other functional changes in the genome. Understanding the location of rs11977670 is a key step in mapping how specific genomic regions may contribute to complex health traits.
Association with Invasive Lobular Carcinoma
Scientific research has identified rs11977670 as a significant genetic marker for invasive lobular carcinoma (ILC) of the breast. Studies have shown that this variant reaches genome-wide significance in its association with ILC, with an odds ratio indicating a modest increase in risk for carriers of the risk allele. Notably, the association appears to be specific to lobular breast cancer, showing a much weaker or negligible link to invasive ductal carcinoma (IDC). This specificity suggests that the biological pathways involved in the development of lobular breast cancer may be distinct from those of other breast cancer subtypes. While the evidence for this association is considered moderate to strong in the context of genetic epidemiology, it is important to remember that this variant is only one of many factors that contribute to cancer risk.
Population Frequency and Interpretation
The rs11977670 variant is considered common across various populations. In genetic studies, common variants are those that appear frequently in the general population, which allows researchers to perform large-scale case-control analyses to determine their statistical impact on disease risk. Because the variant is common, the presence of the risk allele does not automatically imply a high risk of disease; rather, it represents a small, incremental change in the statistical probability of developing the condition. Genetic risk is typically polygenic, meaning it is influenced by the cumulative effect of many different variants across the genome, as well as environmental and lifestyle factors. Consequently, the presence of this variant should be viewed as a single piece of a much larger and more complex biological puzzle.
What This Information Means for You
It is essential to understand that identifying a genetic predisposition through a SNP like rs11977670 is not a medical diagnosis. Genetic associations are statistical observations made across large groups of people and cannot predict the health outcome of any single individual. If you have received information about your genotype for this variant, it is important to discuss these results with a qualified healthcare provider or a genetic counselor. They can help you interpret the findings within the context of your personal and family medical history. You should never make changes to your health management, screening schedules, or medical treatments based solely on genetic data without professional clinical guidance. Always prioritize evidence-based screening recommendations provided by your doctor, as these are tailored to your overall health profile rather than a single genetic marker.
How common is this variant?
The rs11977670 variant is a common polymorphism found across diverse ancestral populations, with the G and A alleles appearing at significant frequencies in the general population.
Frequently asked questions
Does having the rs11977670 variant mean I will get breast cancer?
No. This variant is associated with a statistical increase in risk for a specific type of breast cancer, but it is not a diagnostic marker. Most people who carry this variant will never develop breast cancer, as disease risk is influenced by many genetic and environmental factors.
Should I get tested for rs11977670?
Routine testing for this specific SNP is not currently recommended as a standard clinical practice for the general population. If you are concerned about your breast cancer risk, you should speak with a doctor about established screening guidelines based on your family history and personal health.
Is rs11977670 the same as a BRCA1 or BRCA2 mutation?
No. BRCA1 and BRCA2 are high-penetrance genes where specific mutations can significantly increase the risk of breast and ovarian cancer. In contrast, rs11977670 is a common, low-penetrance variant that contributes only a small amount to overall risk.
Can I change my risk if I have this variant?
While you cannot change your genetics, you can manage your overall health through lifestyle choices and adherence to recommended cancer screening programs. Discuss your specific risk profile with a healthcare professional to determine the best approach for your health.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11977670?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant alters the expression of microRNA MIR146A and is significantly associated with acute rejection risk in kidney transplant recipients of African American descent.
The T allele of this variant is associated with ischemic stroke risk, with regular exercise shown to attenuate this genetic predisposition.
This variant is identified as pathogenic and associated with Dubin-Johnson syndrome.
This variant is classified as pathogenic and is associated with 21-hydroxylase deficiency.
This pathogenic variant is associated with Usher syndrome type 1D, which affects hearing and vision.
This variant is classified as pathogenic and is linked to the development of Cataract 19.